Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction

Mutsuharu Hayashi, Yoshinari Yasuda, Susumu Suzuki, Manaka Tagaya, Takehiro Ito, Tomohito Kamada, Masataka Yoshinaga, Yoshinori Sugishita, Wakaya Fujiwara, Hiroatsu Yokoi, Yukio Ozaki, Hideo Izawa

Research output: Contribution to journalArticle

Abstract

Although the renin–angiotensin system (RAS) is counter-balanced by a salt-sensitive mechanism in the hypertensive state, both are reported to be up-regulated in chronic kidney disease (CKD) patients. We conducted this study to evaluate the associations among the RAS, renal function, hypertension, and atherosclerosis, as well as to identify markers for salt-sensitivity. A total of 213 pre-dialysis CKD patients with preserved cardiac function (EF >50 %) were enrolled. Their renal and cardiac biochemical markers and plasma renin activity (PRA) were measured, and echocardiography and carotid artery ultrasound were performed. Their salt intake was estimated by the NaCl excretion from a 24-h collected urine sample. The PRA was higher in patients with hypertension (p = 0.018), and had a significant negative correlation with the eGFR (r = −0.23, p = 0.0067). Importantly, the PRA had a strong negative correlation with the brain natriuretic peptide (BNP) level (r = −0.28, p = 0.017) regardless of whether the patients were being treated with RAS inhibitors. The BNP level was related to the renal functions (eGFR: p = 0.001, ACR: p = 0.009). There was a significant positive correlation between the BNP level and carotid intima–media thickness (p < 0.001). A multivariate analysis revealed that older age and an excess of NaCl excretion were independent predictors of BNP elevation (p = 0.02 and 0.003, respectively). Our analysis revealed details of the counterbalance between BNP and PRA, as well as identifying that excess salt intake is a predictor of BNP elevation. These results indicate that the BNP could be a possible valuable marker for salt sensitivity, and that high salt sensitivity could facilitate atherosclerosis in CKD patients.

Original languageEnglish
Pages (from-to)279-286
Number of pages8
JournalHeart and Vessels
Volume32
Issue number3
DOIs
Publication statusPublished - 01-03-2017

Fingerprint

Brain Natriuretic Peptide
Chronic Renal Insufficiency
Salts
Renin
Atherosclerosis
Kidney
Renal Hypertension
Carotid Arteries
Echocardiography
Dialysis
Multivariate Analysis
Biomarkers
Urine
Hypertension

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Hayashi, Mutsuharu ; Yasuda, Yoshinari ; Suzuki, Susumu ; Tagaya, Manaka ; Ito, Takehiro ; Kamada, Tomohito ; Yoshinaga, Masataka ; Sugishita, Yoshinori ; Fujiwara, Wakaya ; Yokoi, Hiroatsu ; Ozaki, Yukio ; Izawa, Hideo. / Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction. In: Heart and Vessels. 2017 ; Vol. 32, No. 3. pp. 279-286.
@article{ebd8a400378948b4b04cbb776780af88,
title = "Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction",
abstract = "Although the renin–angiotensin system (RAS) is counter-balanced by a salt-sensitive mechanism in the hypertensive state, both are reported to be up-regulated in chronic kidney disease (CKD) patients. We conducted this study to evaluate the associations among the RAS, renal function, hypertension, and atherosclerosis, as well as to identify markers for salt-sensitivity. A total of 213 pre-dialysis CKD patients with preserved cardiac function (EF >50 {\%}) were enrolled. Their renal and cardiac biochemical markers and plasma renin activity (PRA) were measured, and echocardiography and carotid artery ultrasound were performed. Their salt intake was estimated by the NaCl excretion from a 24-h collected urine sample. The PRA was higher in patients with hypertension (p = 0.018), and had a significant negative correlation with the eGFR (r = −0.23, p = 0.0067). Importantly, the PRA had a strong negative correlation with the brain natriuretic peptide (BNP) level (r = −0.28, p = 0.017) regardless of whether the patients were being treated with RAS inhibitors. The BNP level was related to the renal functions (eGFR: p = 0.001, ACR: p = 0.009). There was a significant positive correlation between the BNP level and carotid intima–media thickness (p < 0.001). A multivariate analysis revealed that older age and an excess of NaCl excretion were independent predictors of BNP elevation (p = 0.02 and 0.003, respectively). Our analysis revealed details of the counterbalance between BNP and PRA, as well as identifying that excess salt intake is a predictor of BNP elevation. These results indicate that the BNP could be a possible valuable marker for salt sensitivity, and that high salt sensitivity could facilitate atherosclerosis in CKD patients.",
author = "Mutsuharu Hayashi and Yoshinari Yasuda and Susumu Suzuki and Manaka Tagaya and Takehiro Ito and Tomohito Kamada and Masataka Yoshinaga and Yoshinori Sugishita and Wakaya Fujiwara and Hiroatsu Yokoi and Yukio Ozaki and Hideo Izawa",
year = "2017",
month = "3",
day = "1",
doi = "10.1007/s00380-016-0867-1",
language = "English",
volume = "32",
pages = "279--286",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "3",

}

Hayashi, M, Yasuda, Y, Suzuki, S, Tagaya, M, Ito, T, Kamada, T, Yoshinaga, M, Sugishita, Y, Fujiwara, W, Yokoi, H, Ozaki, Y & Izawa, H 2017, 'Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction', Heart and Vessels, vol. 32, no. 3, pp. 279-286. https://doi.org/10.1007/s00380-016-0867-1

Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction. / Hayashi, Mutsuharu; Yasuda, Yoshinari; Suzuki, Susumu; Tagaya, Manaka; Ito, Takehiro; Kamada, Tomohito; Yoshinaga, Masataka; Sugishita, Yoshinori; Fujiwara, Wakaya; Yokoi, Hiroatsu; Ozaki, Yukio; Izawa, Hideo.

In: Heart and Vessels, Vol. 32, No. 3, 01.03.2017, p. 279-286.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction

AU - Hayashi, Mutsuharu

AU - Yasuda, Yoshinari

AU - Suzuki, Susumu

AU - Tagaya, Manaka

AU - Ito, Takehiro

AU - Kamada, Tomohito

AU - Yoshinaga, Masataka

AU - Sugishita, Yoshinori

AU - Fujiwara, Wakaya

AU - Yokoi, Hiroatsu

AU - Ozaki, Yukio

AU - Izawa, Hideo

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Although the renin–angiotensin system (RAS) is counter-balanced by a salt-sensitive mechanism in the hypertensive state, both are reported to be up-regulated in chronic kidney disease (CKD) patients. We conducted this study to evaluate the associations among the RAS, renal function, hypertension, and atherosclerosis, as well as to identify markers for salt-sensitivity. A total of 213 pre-dialysis CKD patients with preserved cardiac function (EF >50 %) were enrolled. Their renal and cardiac biochemical markers and plasma renin activity (PRA) were measured, and echocardiography and carotid artery ultrasound were performed. Their salt intake was estimated by the NaCl excretion from a 24-h collected urine sample. The PRA was higher in patients with hypertension (p = 0.018), and had a significant negative correlation with the eGFR (r = −0.23, p = 0.0067). Importantly, the PRA had a strong negative correlation with the brain natriuretic peptide (BNP) level (r = −0.28, p = 0.017) regardless of whether the patients were being treated with RAS inhibitors. The BNP level was related to the renal functions (eGFR: p = 0.001, ACR: p = 0.009). There was a significant positive correlation between the BNP level and carotid intima–media thickness (p < 0.001). A multivariate analysis revealed that older age and an excess of NaCl excretion were independent predictors of BNP elevation (p = 0.02 and 0.003, respectively). Our analysis revealed details of the counterbalance between BNP and PRA, as well as identifying that excess salt intake is a predictor of BNP elevation. These results indicate that the BNP could be a possible valuable marker for salt sensitivity, and that high salt sensitivity could facilitate atherosclerosis in CKD patients.

AB - Although the renin–angiotensin system (RAS) is counter-balanced by a salt-sensitive mechanism in the hypertensive state, both are reported to be up-regulated in chronic kidney disease (CKD) patients. We conducted this study to evaluate the associations among the RAS, renal function, hypertension, and atherosclerosis, as well as to identify markers for salt-sensitivity. A total of 213 pre-dialysis CKD patients with preserved cardiac function (EF >50 %) were enrolled. Their renal and cardiac biochemical markers and plasma renin activity (PRA) were measured, and echocardiography and carotid artery ultrasound were performed. Their salt intake was estimated by the NaCl excretion from a 24-h collected urine sample. The PRA was higher in patients with hypertension (p = 0.018), and had a significant negative correlation with the eGFR (r = −0.23, p = 0.0067). Importantly, the PRA had a strong negative correlation with the brain natriuretic peptide (BNP) level (r = −0.28, p = 0.017) regardless of whether the patients were being treated with RAS inhibitors. The BNP level was related to the renal functions (eGFR: p = 0.001, ACR: p = 0.009). There was a significant positive correlation between the BNP level and carotid intima–media thickness (p < 0.001). A multivariate analysis revealed that older age and an excess of NaCl excretion were independent predictors of BNP elevation (p = 0.02 and 0.003, respectively). Our analysis revealed details of the counterbalance between BNP and PRA, as well as identifying that excess salt intake is a predictor of BNP elevation. These results indicate that the BNP could be a possible valuable marker for salt sensitivity, and that high salt sensitivity could facilitate atherosclerosis in CKD patients.

UR - http://www.scopus.com/inward/record.url?scp=84978032353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978032353&partnerID=8YFLogxK

U2 - 10.1007/s00380-016-0867-1

DO - 10.1007/s00380-016-0867-1

M3 - Article

VL - 32

SP - 279

EP - 286

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 3

ER -